|
"hong r l"的相關文件
顯示項目 1-10 / 239 (共24頁)
1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
| 國立成功大學 |
2023 |
Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial
|
Chan, A.T.C.;Lee, V.H.F.;Hong, R.-L.;Ahn, M.-J.;Chong, W.Q.;Kim, S.-B.;Ho, G.F.;Caguioa, P.B.;Ngamphaiboon, Ngamphaiboon N.;Ho, C.;Aziz, M.A.S.A.;Ng, Q.S.;Yen, C.-J.;Soparattanapaisarn, N.;Ngan, R.K.-C.;Kho, S.K.;Tiambeng, M.L.A.;Yun, T.;Sriuranpong, V.;Algazi, Algazi A.P.;Cheng, A.;Massarelli, E.;Swaby, R.F.;Saraf, Saraf S.;Yuan, J.;Siu, L.L. |
| 國立成功大學 |
2023 |
A Phase 1b/2 Study of Alpelisib in Combination with Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
|
Razak, A.R.A.;Wang, H.-M.;Chang, J.-Y.;Ahn, M.-J.;Munster, P.;Blumenschein, G.;Jr;Solomon, B.;Lim, D.W.-T.;Hong, R.-L.;Pfister, D.;Saba, N.F.;Lee, S.-H.;van, Herpen C.;Quadt, C.;Bootle, D.;Blumenstein, L.;Demanse, Demanse D.;Delord, J.-P. |
| 臺大學術典藏 |
2022-09-06T08:57:05Z |
Overexpression of p53 predicts shorter survival in diffuse type gastric cancer
|
Lee W.-J.; Shun C.-T.; Hong R.-L.; MING-SHIANG WU; Chang K.-J.; Chen K.-M. |
| 臺大學術典藏 |
2022-09-06T08:56:49Z |
Alterations of BAT-26 identify a subset of gastric cancer with distinct clinicopathologic features and better postoperative prognosis
|
MING-SHIANG WU; Lee C.-W.; Sheu J.-C.; Shun C.-T.; Wang H.-P.; Hong R.-L.; Lee W.-J.; Lin J.-T. |
| 臺大學術典藏 |
2022-08-23T02:35:03Z |
Polatuzumab vedotin�Vbased salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience
|
Wang Y.-W.; Tsai X.C.-H.; Hou H.-A.; Tien F.-M.; Liu J.-H.; Chou W.-C.; Ko B.-S.; Chen Y.-W.; Lin C.-C.; Cheng C.-L.; Lo M.-Y.; Lin Y.-C.; Lu L.-C.; Wu S.-J.; SUNG-HSIN KUO; Hong R.-L.; Huang T.-C.; Yao M. |
| 臺大學術典藏 |
2022-08-19T00:21:13Z |
Unexpected rapid progression of metastatic adenoid cystic carcinoma during treatment with imatinib mesylate
|
Lin C.-H.; Yen R.-F.; Jeng Y.-M.; Tzen C.-Y.; CHIUN HSU; Hong R.-L. |
| 臺大學術典藏 |
2022-08-19T00:20:57Z |
Factors impacting prognosis prediction in BCLC stage C and Child-Pugh Class A hepatocellular carcinoma patients in prospective clinical trials of systemic therapy
|
Yang C.-H.; Hong R.-L.; Hsu C.-H.; Chengb A.-L.; Chang D.-Y.; Hu F.-C.; Shao Y.-Y.; CHIUN HSU; Lin Z.-Z. |
| 臺大學術典藏 |
2022-08-12T06:29:09Z |
A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancers
|
Yeh K.-H.; Cheng A.-L.; Lin M.-T.; Hong R.-L.; Hsu C.-H.; Lin J.-F.; KING-JEN CHANG; Lee P.-H.; Chen Y.-C. |
| 臺大學術典藏 |
2022-08-12T06:29:04Z |
Overexpression of p53 predicts shorter survival in diffuse type gastric cancer
|
Lee W.-J.; Shun C.-T.; Hong R.-L.; Wu M.-S.; KING-JEN CHANG; Chen K.-M. |
| 臺大學術典藏 |
2022-06-27T07:07:42Z |
The diagnostic and prognostic effectiveness of F-18 sodium fluoride PET-CT in detecting bone metastases for hepatocellular carcinoma patients
|
Yen R.-F.; Chen C.-Y.; Cheng M.-F.; Wu Y.-W.; Shiau Y.-C.; Wu K.; Hong R.-L.; CHONG-JEN YU; Wang K.-L.; Yang R.-S. |
顯示項目 1-10 / 239 (共24頁)
1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
|
